​

Funding Round

Series A - Icosavax

Series A - Icosavax

Investment Firm

Overview

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Announced Date

Oct 03, 2019

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Qiming Venture Partners USA

Qiming Venture Partners USA

Qiming Venture Partners USA is a early_stage_venture and post_ipo firm.

Participant Investors

5

Investor Name
Participant InvestorQiming Venture Partners USA
Participant InvestorSanofi
Participant InvestorSanofi Ventures
Participant Investor+ND Capital
Participant InvestorAdams Street Partners

Round Details and Background

Icosavax raised $51000000 on 2019-10-03 in Series A

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.

Company Funding History

7

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 30, 2020
Grant - Icosavax
1-10.0M
Jan 01, 2017
Pre Seed Round - Icosavax
1-undefined
May 22, 2023
Post-IPO Equity - Icosavax
3-67.8M
Aug 01, 2020
Grant - Icosavax
1-6.5M

Recent Activity

There is no recent news or activity for this profile.